Ibio Inc (NYSE American:IBIO)
| 2.98 Delayed Data As of Dec 01 |  -0.29 / -8.87%Today’s Change | 2.80 Today|||52-Week Range 52.00 | -66.47% Year-to-Date |
Latest IBIO News | Press Releases
No recent news for Ibio Inc.
Today’s Trading
| Previous close | 3.27 |
| Today’s open | 2.91 |
| Day’s range | 2.91 - 3.07 |
| Volume | 206,828 |
| Average volume (3 months) | 32,811 |
| Market cap | $4.2M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +8.12% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EVOKEvoke Pharma Inc | 0.00 | 0.00% |
| QNNTFQuantum Genomics SA | 0.00 | 0.00% |
| ---- | ||
| SCNIScinai Immunotherape... | 0.00 | 0.00% |
Data as of 3:49pm ET, 11/30/2023
Financials
| Last reporting date | September 26, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$65.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Bryan, Texas |
Forecasts
